Assessing a new injectable gel for improving mid-face volume

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of NOA VOLUME, a crosslinked Hyaluronic Acid gel, in restoring mid-face volume in adults compared to JUVÉDERM VOLUMA XC. Participants will be divided into two cohorts, receiving either NOA VOLUME or VOLUMA XC, with follow-up assessments to determine improvements in facial fullness. The study aims to provide a minimally invasive solution for individuals experiencing volume loss due to aging.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Has moderate (3), significant (4), or severe (5) mid-face volume deficit on the 5-point photonumeric MFVDS based on evaluating investigator's (EI) live assessment.
* Mid-face is amenable to achieving at least a 1-point improvement in MFVDS score with the allowed injection volume in the treating investigator's (TI) judgement.

Exclusion Criteria:

* Significant skin laxity in the midface in the opinion of the TI.
* Significant skin pigmentation disorders or discoloration in the mid-face area that would interfere with the visual assessment of the mid-face area.
* Current cutaneous inflammatory or infectious processes (e.g., acne, herpes), abscess, unhealed wound, or cancerous or precancerous lesion on the face.

Where it's running

• Total Skin and Beauty Dermatology Center /ID# 258164
  Birmingham, Alabama, United States Recruiting
• Advanced Research Associates - Glendale /ID# 276812
  Glendale, Arizona, United States Recruiting
• West Dermatology La Jolla /ID# 278590
  San Diego, California, United States Recruiting
• Susan H. Weinkle MD /ID# 258160
  Bradenton, Florida, United States Recruiting
• Hevia Cosmetic Dermatology /ID# 258165
  Coral Gables, Florida, United States Recruiting
• Skin Research Institute LLC /ID# 258158
  Coral Gables, Florida, United States Recruiting

Study contacts

• Study coordinator: Abbvie Call Center
• Email: abbvieclinicaltrials@abbvie.com
• Phone: 844-663-3742

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Alcarisa (hyaluronic acid) injections to restore mid-face volume

  Doctors will try Alcarisa hyaluronic acid injections to restore mid-face volume in adults 30 to 65 with moderate to severe cheek volume loss.

  Recruiting at 2 sites Espad Pharmed · Tehran, Tehran Province and 1 other locations · NCT07126912

• How trosunilimab moves through the body after IV and SC doses in healthy adults

  This study tests how trosunilimab behaves in the body and how the immune system reacts to it after intravenous and subcutaneous doses in healthy adults.

  Recruiting Phase 1 AbbVie · Grayslake, Illinois · NCT07925983

• Real-world use of mirvetuximab soravtansine in FRα-positive platinum-resistant ovarian, fallopian tube, and peritoneal cancer

  This study tests how mirvetuximab soravtansine works in real-world adults with FRα-positive platinum-resistant ovarian, fallopian tube, or peritoneal cancer.

  Recruiting AbbVie · Vienna · NCT07896421

• NOA HYDRATION facial gel: see if it can improve skin smoothness

  This study tests whether NOA HYDRATION injectable gel can improve facial skin quality and smoothness in Chinese adults.

  Recruiting at 4 sites Phase 3 AbbVie · Beijing, Beijing Municipality and 3 other locations · NCT07880756

• Combination of two botulinum toxins for upper facial lines in adults

  This study tests whether a single treatment that combines trenibotulinumtoxinE with onabotulinumtoxinA can improve moderate to severe upper facial lines in adults.

  Recruiting at 21 sites Phase 2 AbbVie · Birmingham, Alabama and 20 other locations · NCT07871513

• ABBV-7828 safety and food effect study in healthy adults

  This study tests ABBV-7828 versus placebo in healthy adults to see how safe it is, how it behaves in the body, and how food changes its effects.

  Recruiting Phase 1 AbbVie · Grayslake, Illinois · NCT07856706

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.